Advanced Search
CHENG Jing, WU Gang, PENG Gang, HUANG Jing. Clinical Observation of Erythropoietin in Treating the Malignant Tumour Anemia[J]. Cancer Research on Prevention and Treatment, 2005, 32(08): 511-512. DOI: 10.3971/j.issn.1000-8578.1276
Citation: CHENG Jing, WU Gang, PENG Gang, HUANG Jing. Clinical Observation of Erythropoietin in Treating the Malignant Tumour Anemia[J]. Cancer Research on Prevention and Treatment, 2005, 32(08): 511-512. DOI: 10.3971/j.issn.1000-8578.1276

Clinical Observation of Erythropoietin in Treating the Malignant Tumour Anemia

  • Objective  To observe the effect of recombinant human erythropietin ( rHuEpo) in t reating malignant tumour anemia (MTA) . Methods  Thirty cases of treated group were treated with rHuEpo 10000 U, qod, lasted for 8 weeks . Thirty cases of control group were treated with support cares and the blood transfusion. Results  The overall response rates of treated and control group were 73. 3 %(22/30) and 13. 3 % (4/ 30) respectively, and the increased Hb of treated group is more higher than that of control group ( P < 0. 01) . Conclusion  rHuEpo is effective and safe in treating MTA.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return